Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: A retrospective study in patients with advanced prostate cancer

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wuethrich, Patrick Y ^a   Thalmann, George N ^a   Studer, Urs E ^a   Burkhard, Fiona C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPIVACAINE; FENTANYL; KETOROLAC; MORPHINE; PARACETAMOL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER GROWTH; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT RECURRENCE FREE SURVIVAL; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE ANALGESIA; PROSTATE CANCER; PROSTATECTOMY; RETROPUBIC RADICAL PROSTATECTOMY; RETROSPECTIVE STUDY; SURVIVAL TIME; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; SURVIVAL; TIME; TREATMENT OUTCOME;

AGED; ANALGESIA, EPIDURAL; ANESTHESIA, GENERAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888434551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072873     Document Type: Article

References (29)

1. Forget P, Collet V, Lavand'homme P, De Kock M (2011) Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 27: 233-240.
2. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE (2008) Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 107: 325-332. doi: 10.1213/ane.0b013e3181770f55. PubMed: 18635504.
3. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105: 660-664. doi: 10.1097/00000542-200610000-00008. PubMed: 17006061.
4. Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR et al. (2011) Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 342: d1491. doi:10.1136/bmj.d1491. PubMed: 21447587.
5. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI et al. (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109: 180-187. doi: 10.1097/ALN.0b013e31817f5b73. PubMed: 18648226.
6. Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE et al. (2010) Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 113: 570-576. PubMed: 20683253.
7. Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S et al. (2010) Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 57: 107-112. doi:10.1007/s12630-009-9214-7. PubMed: 19911247.
8. Forget P, Tombal B, Scholtès JL, Nzimbala J, Meulders C et al. (2011) Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28: 830-835. doi:10.1097/EJA.0b013e32834b7d9a. PubMed: 21946823.
9. Burkhard FC, Schumacher M, Studer UE (2005) The role of lymphadenectomy in prostate cancer. Nat Clin Pract Urol 2: 336-342. doi:10.1038/ncpcardio0242. PubMed: 16474786.
10. Burkhard FC, Schumacher MC, Studer UE (2006) An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated. Nat Clin Pract Urol 3: 454-455. doi: 10.1038/ncpuro0558. PubMed: 16964180.
11. Burkhard FC, Studer UE (2008) The role of lymphadenectomy in high risk prostate cancer. World J Urol 26: 231-236. doi:10.1007/s00345-008-0251-6. PubMed: 18369636.
12. Jhaveri FM, Zippe CD, Klein EA, Kupelian PA (1999) Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 54: 884-890. doi: 10.1016/S0090-4295(99)00252-6. PubMed: 10565752.
13. Ward JF, Moul JW (2005) Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol 2: 174-182. doi:10.1038/ncpgasthep0137. PubMed: 16474760.
14. Isbarn H, Wanner M, Salomon G, Steuber T, Schlomm T et al. (2010) Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. BJU Int 106: 37-43. PubMed: 20002667.
15. Loeb S, Smith ND, Roehl KA, Catalona WJ (2007) Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 69: 1170-1175. doi:10.1016/j.urology.2007.02.054. PubMed: 17572209.
16. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H (2005) Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95: 751-756. doi:10.1111/j.1464-410X.2005.05394.x. PubMed: 15794776.
17. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S et al. (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82: 492-497. doi:10.1213/00000539-199603000-00011. PubMed: 8623949.
18. Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H (2000) Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42: 73-78. doi:10.1002/(SICI)1097-0045(20000101)42:1. PubMed: 10579801.
19. Basler JW, Piazza GA (2004) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. J Urol 171: S59-S62; discussion S62-53 doi: 10.1097/01.ju.0000107839.06670.27. PubMed: 14713756.
20. Lucia MS, Torkko KC (2004) Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale. J Urol 171: S30-S34; discussion S35 doi:10.1097/01.ju. 0000108142.53241.47. PubMed: 14713750.
21. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ et al. (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97: 1523-1531. doi: 10.1038/sj.bjc.6604057. PubMed: 17971769.
22. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R et al. (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15: 2042-2052. doi:10.1245/s10434-008-9890-5. PubMed: 18398660.
23. James ND, Sydes MR, Mason MD, Clarke NW, Anderson J et al. (2012) Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol 13: 549-558. doi:10.1016/S1470-2045(12)70088-8. PubMed: 22452894.
24. Ben-Eliyahu S, Shakhar G, Rosenne E, Levinson Y, Beilin B (1999) Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 91: 732-740. doi: 10.1097/00000542-199909000-00026. PubMed: 10485785.
25. Brand JM, Kirchner H, Poppe C, Schmucker P (1997) The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 83: 190-194. doi: 10.1006/clin.1997.4351. PubMed: 9143381.
26. Devlin EG, Clarke RS, Mirakhur RK, McNeill TA (1994) Effect of four i.v. induction agents on T-lymphocyte proliferations to PHA in vitro. Br J Anaesth 73: 315-317. doi:10.1093/bja/73.3.315. PubMed: 7946855.
27. Markovic SN, Knight PR, Murasko DM (1993) Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 78: 700-706. doi: 10.1097/00000542-199304000-00013. PubMed: 8466070.
28. Markovic SN, Murasko DM (1993) Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells. Cell Immunol 151: 474-480. doi:10.1006/cimm.1993.1256. PubMed: 8402951.
29. Shapiro J, Jersky J, Katzav S, Feldman M, Segal S (1981) Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 68: 678-685. doi:10.1172/JCI110303. PubMed: 7276167.